EUVIMEDEUVIMED entdecken
Open Access

Optimizing Treatment Allocation in Randomized Clinical Trials by Leveraging Baseline Covariates

Wei Zhang iD, Zhiwei Zhang iD, Aiyi Liu iD

Biometrics · 01.12.2023 · 79 (4) · 2815-2829

DOI: 10.1111/biom.13914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrics, online erschienen am 28.08.2023. Verfasst von Wei Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China. Hauptthemen laut MEDLINE: Models, Statistical, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We consider the problem of optimizing treatment allocation for statistical efficiency in randomized clinical trials. Optimal allocation has been studied previously for simple treatment effect estimators such as the sample mean difference, which are not fully efficient in the presence of baseline covariates. More efficient estimators can be obtained by incorporating covariate information, and modern machine learning methods make it increasingly feasible to approach full efficiency. Accordingly, we derive the optimal allocation ratio by maximizing the design efficiency of a randomized trial, assuming that an efficient estimator will be used for analysis. We then expand the scope of optimization by considering covariate-dependent randomization (CDR), which has some flavor of an observational study but provides the same level of scientific rigor as a standard randomized trial. We describe treatment effect estimators that are consistent, asymptotically normal, and (nearly) efficient under CDR, and derive the optimal propensity score by maximizing the design efficiency of a CDR trial (under the assumption that an efficient estimator will be used for analysis). Our optimality results translate into optimal designs that improve upon standard practice. Real-world examples and simulation results demonstrate that the proposed designs can produce substantial efficiency improvements in realistic settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, StatisticalRandomized Controlled Trials as TopicComputer SimulationPropensity ScoreHumans

Stichwörter der Autor:innen

augmentationinformation boundoptimal designpropensity scoresemiparametric theorysuper learner

Autor:innen und Institutionen

  • Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.
  • Biostatistics Innovation Group, Gilead Sciences, Foster City, California, USA.
  • Biostatistics and Bioinformatics Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryl…

ORCID-Profile: Wei Zhang, Zhiwei Zhang, Aiyi Liu

Förderung

  • Intramural NIH HHS
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, W., Zhang, Z., & Liu, A. (2023). Optimizing Treatment Allocation in Randomized Clinical Trials by Leveraging Baseline Covariates. Biometrics, 79(4), 2815-2829. https://doi.org/10.1111/biom.13914

Vancouver

Zhang W, Zhang Z, Liu A. Optimizing Treatment Allocation in Randomized Clinical Trials by Leveraging Baseline Covariates. Biometrics. 2023;79(4):2815-2829. doi:10.1111/biom.13914

BibTeX
@article{Zhang2023,
  author = {Zhang, Wei and Zhang, Zhiwei and Liu, Aiyi},
  title = {Optimizing Treatment Allocation in Randomized Clinical Trials by Leveraging Baseline Covariates},
  journal = {Biometrics},
  year = {2023},
  volume = {79},
  number = {4},
  pages = {2815--2829},
  doi = {10.1111/biom.13914}
}
Kostenlos starten →